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ABSTRACT 
 
China has attracted increasing amounts of foreign investment since it opened its doors 
to the world and whilst many analysts have focused on foreign investment in popular 
areas, little has been written about medical device investment. The purpose of this 
article is to analyze the status of China’s medical device market from the perspective 
of the healthcare industry and its important market drivers; the study reveals that the 
medical device market has significant growth potential. This article aims to identify 
and assess the profitable sectors of medical device technologies as a guide for 
international companies and investors. 
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1. Introduction 
   The economy in China has experienced 30-years of rapid growth and obtained 
remarkable success ever since the great reforms and opening-up policy. This reform in 
China represents a fundamental change and overhaul of China’s: value system, law 
making, institutional infrastructure, and socio-economic structure; this has been 
axiomatic for mobilizing foreign investment. While economic cycles and uncertainties 
have affected several global industries in the last few years, the medical device 
industry has gained from the benefits of earlier investments and delivered 
incomparable improvements in the quality of people’s lives in the developed countries 
(Panescu, 2009). There is an urgent need for China and the world to better understand 
the Chinese medical device market and how it compares with other industries in 
China. One powerful development supporting a positive hypothesis is that people are 
paying more attention to their health due to the improved quality of life. Another is 
that treatment of some serious diseases requires high quality medical devices. So the 
research question arising is: What are the important features of the Chinese healthcare 
market indicating the investment potential of the Chinese medical device market?   
   Whilst there is some literature on the medical device industry and technology 
investment, it is narrowly focused and more general investment data is scarce. It is on 
the measure of profitability that the medical device industry truly stands out, as it has 
a more consistent rate of growth than nearly every other industry (Kruger, 2005). The 
medical device industry is increasingly significant in the contribution it makes to 
countries’ economic productivity (Faulkner, 2009). If the market is being fully 
exploited, the principal difference between any two production locations is likely to 
be labor costs. When product standardization and market saturation give rise to cost 
pressures and price competition in developed countries, those companies that want to 
increase their export business, transfer technology and investment abroad, which 
means the developed countries shift production to the developing countries (Hill, 
2009). The developing countries technological capabilities are often improved and 
expanded, this results in a stable technical ability enhancement via continuous 
accumulation. Technological capability enhancement is strongly correlated with 
foreign investment growth and vice versa (Cantwell, 1999; Narula, 1996). When a 
technological industrial firm in a developed country invests in a developing country 
(this country should gradually assimilate the economic structure), not only is the 
knowledge content of the investment important but it will also be directed towards a 
growth industry (Dunning, 1972). This explains why many US, German and Japanese 
companies have been able to create an important presence in the newer Chinese 
medical devices industry; this is because these countries were much more advanced in 
this technology area than China. China has substantial size and a high growth rate in 
its consumer market, which drives sales of service from healthcare, this is the reason 
why China is attractive to foreign investors (Cui & Liu, 2000). As an emerging market, 
China offers long-term growth opportunities that no longer exists in relatively 
saturated and highly competitive developed markets (Sakarya, 2007).  
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   Investment clearly implies strong consumption now, with the expectation of more 
consumption at a later time (Au & Au, 1983). Despite the low rates of return on 
investment, China has attracted a great deal of foreign investment in many industries, 
while other selected countries were not attracting investment, or are even losing 
foreign capital in Hsiao’s research (Frank Hsiao & Hsiao;, 2004). With adopted 
foreign capital, management know-how and trained labor, China possesses the 
capacity to absorb high technology industry, especially in the medical device industry 
(Liu & K. Daly, 2011). China has been the fastest growing economy, expanding at 
10.0 percent annually, driven by exports and investment. High priority is given to 
transform the economic structure from an export driven to a consumption driven 
economy during the period of the “National 12th Five-Year Plan”.1 (Frost & Sullivan, 
2010)  
   Medical devices can guide optimized medical intervention plans, treat people’s 
illnesses and reduce the discomfort caused by the disease. High quality, well designed 
medical devices provide safe and effective clinical care for patients (Martin, Norris, 
Murphy, & Crowe, 2008). Of all the new high technology industries, medical device 
investment has the most potential. The healthcare industry has emerged as a driver of 
economic growth supported by government initiatives and increased investment. The 
size of the medical device market continues to exhibit a rapid growth trend in China, 
the growth rate recently reaching 23%, the market scale has reached approximately 19 
billion U.S. dollars (USD) (Medical Economic News, 2010). However, the global 
medical device market is already over USD 300 billion, it was about 16 times more 
than China’s in 2010 (World Health Organization, 2011). The US, Japan, Germany, 
France and Italy account for 13.1% of global population and 76% of global medical 
device use, conversely, the five most populous countries: China, India, Brazil, 
Indonesia and Pakistan account for about half of the global population but only 4.4% 
of medical devices used in the world (Zapiain, 2011). According to the Frost & 
Sullivan forecast, the growth rate of global medical devices will increase 4% to 6% 
annually in the next few years and China’s entire medical device market is expected to 
double, reaching USD 53.7 billion by 2015 (Frost & Sullivan, 2010). Moreover, our 
study also finds that the recent development plans of the Chinese government are 
aimed at expanding the healthcare infrastructure across the rural-urban space. 
Opportunities exist in pharmaceutical, medical devices and equipment, outsourcing 
and biotechnology.  
   Since China opened the door to the world, its economic reforms have attracted 
more and more foreign investment. During this economic period there has been 
massive research into the impacts of foreign direct investment (FDI). A literature 
review of FDI and trade in health services reveals FDI involves the increased 
commercialization of the health care sector (Smith, 2004). Researchers used the 
bibliometrics analysis of many literature reviews, to show the main research streams 
on FDI into China (Fetscherin, Voss, & Gugler, 2010). Although there is growing 
                                                             
1
 Five-Year Plan (FYP) is a series of social and economic development initiatives, which renews every five years. 
The Five-Year Plan was shaped by the Communist Party of China, who plays a leading role in mapping strategies 
for China’s economic development, setting growth targets and launching reforms. First FYP: 1953-1957, the rest 
can be done in the same manner. So 11th FYP is from 2006-2010 and 12th FYP is from 2011-2015. 
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interest in investment in China, analysis of the medical device area has been slow to 
develop, but the sector is growing in importance with the improved realization that 
investment in the medical technology area, especially medical devices, produces 
exceptional value.  
   Based on these facts, this article aims to explore the potential and the investment 
opportunities in the Chinese medical device market. The purpose of this article is 
twofold. Firstly, it illustrates the strength of the Chinese medical device market from 
the perspective of time lines through a comparative analysis of its past and present 
performance. Secondly, it seeks to understand the medical device market in China by 
conducting a comparative study of secondary data.  
   This article contributes on several fronts as literature on investment in medical 
devices is scarce; this article contributes to the literature on both investment and the 
medical device market. It extracts technology investment theories from foreign 
investment theories. The medical device market has become a promising market in 
the world in recent years, especially since the Chinese government is more concerned 
about healthcare than before. Relevant policies on medical device investment will be 
helpful to investors doing business in this area. More and more business research will 
focus on the medical device investment area in the future. Few papers focus on 
investment in the medical device market, with little attention focused on medical 
device regulation. To bridge the gap, this article sheds some light on more detailed 
categories of medical devices that have promising investment potential. Using neural 
network time series predication, we are able to provide some insights on the future 
investment opportunities in the Chinese medical device market.   
   The structure of this article is organized as follows: Section One briefly introduces 
China’s current economic situation and literature on foreign investments in the 
medical device area. Section Two reviews the Chinese medical device market from an 
economic perspective. Section Three illustrates the data collection and methodology 
of this paper. Section Four provides a detailed description of the important drivers for 
Chinese medical device market investment. Section Five discusses the findings of the 
research and Section Six provides the conclusions of the paper. 
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2. Background to the analysis --- Chinese medical device market 
   With the rapid growth of its economy, China has expanded its healthcare 
expenditure. According to the World Bank data, China accounts for only 4% of global 
healthcare expenditure and its healthcare expenditure, as a percentage of gross 
domestic product (GDP)
2
, accounted for just 5.1% of the economy in 2009 (The 
World Bank, 2011a). During the years from 2002 to 2009, China’s total annual 
healthcare expenditure gradually increased. Figure 1 shows total healthcare 
expenditure as a percentage of GDP from 2002 to 2009. By comparison, in 2009, total 
healthcare expenditure, as a percentage of GDP for the: US accounts for 17.7%; 
Germany-11.7%; UK-9.7%; Japan-9.5%, even Brazil is 8.8%, which is higher than 
China (The World Bank, 2011a). The above data suggests that China has the capacity 
to substantially improve its healthcare service. A significant factor is that China has 
the largest population in the world (1,331 million in 2009), which is nearly 4 times 
that of the US (307 million) and about 21 times that of the UK (62 million) in 2009 
(The World Bank, 2011b). More specifically, in 2009, total health expenditure per 
capita
3
 for the US was USD 7,990 and UK was USD 3,445 while China was only 
USD 191 (The World Bank, 2012b). The medical fee-for-service system in China 
leads to many Chinese people needing to pay for the services from their own pocket 
rather than being paid by the government as in the UK and Russia. The medical 
fee-for-service system creates barriers to seeking adequate quantity and quality of care 
for poor families and individuals (Garcia-Diaz & Sosa-Rubi, 2011). Research reports 
that private spending to pay for the medical services has skyrocketed, but the 
percentage of health care costs paid for by the government has decreased in China 
(Schulze, 2001). The Chinese government is trying to make medical services for 
people affordable, especially for the low-income people. The government has 
determined to carry out healthcare reform, and invested 850 billion RMB (about USD 
140 billion) in healthcare systems from 2009 to 2011 (Ministry of Finance of the 
People's Republic of China, 2009). According to the government report, the reform 
has five aspects. (1) establish a basic medical security system and medical insurance 
system; (2) establish a national drug system; (3) improve the basic medical and health 
service system; (4) improve the equality of basic public health services; and (5) 
promote the reform of public hospitals. All this will inevitably lead to spending on 
capital goods, most notably medical devices. (Wong, 2013). Despite these reforms, 
the Chinese government still needs to be vigilant both technically and politically due 
to the challenges of: affordability and accessibility to medical devices (Xu & van de 
Ven, 2013). 
 
                                                             
2
 Gross domestic product (GDP) is the market value of all officially recognized final goods and services produced 
within a country in a given period of time.  
3
 Total health expenditure per capita is the sum of public and private health expenditures as a ratio of total 
population. 
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Fig. 1. China’s total healthcare expenditures and percentage of GDP (2002-2009). 
Source: Chinese Health Statistics Digest 2010, (Ministry of Health of P.R.China, 
2011) 
 
   The global medical device market is highly centralized (APCO Worldwide, 2010). 
The market share of the developed countries accounted for more than 80% of the 
global medical device market share (US: 42.4%, Europe: 33%, Japan: 11%) in 2011 
(Espicom Business Intelligence, 2012). With superior know-how in technology and/or 
management, international companies are typically larger than domestic companies 
and have a competitive advantage due to the economies of scale (Hymer, 1976). 
According to Charles Hill and Vernon’s product life cycle theory, the developed 
countries will export their production and technology from their relatively saturated 
market to the developing countries due to the market pressures and other competition 
in their established markets (Hill, 2009; Vernon, 1966; Vernon & Wells, 1986). 
Despite China only accounting for 3% of the global medical device market share 
(Espicom Business Intelligence, 2012), this study shows that the developing 
countries’ medical device markets are experiencing rapid growth, especially in China. 
Increasing medical expenditure, rising healthcare consumption and health awareness 
improvements are all possible factors in promoting the development of the Chinese 
medical device market. The Chinese government’s healthcare reform has injected 
additional “power” into the development of the medical device market. In fact, by the 
end of 2009, the Chinese medical device industry output value was expected to 
exceed 90 billion RMB, about USD 15 billion, the total percentage of GDP is 0.27% 
according to the National Bureau of Statistics of China, 2010. By the end of 2011, 
China’s medical device industry output value was 110.3 billion RMB, total percentage 
of GDP is 0.29%. Figure 2 shows China’s medical device industry output value and 
its total percentage of GDP, its value continues to climb from 2005 to 2010. 
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Fig. 2. China’s medical device industrial output value and its total (% of GDP). 
Source: National Bureau of Statistics of China, (National Bureau of Statistics of China, 
2011a) 
 
    This study also suggests that the Chinese high-end medical device market is 
dominated by the US, Germany and Japan, it is dependent upon imports from these 
countries. The US is the most significant medical device market in the world. Close to 
60% of all medical devices consumed around the world are produced by American 
companies (Kruger, 2005). According to the APCO Worldwide market analysis report, 
in China, 90% of value-added high-tech medical devices are foreign made, which 
accounts for 70% of China’s medical device market (APCO Worldwide, 2010). These 
high-tech medical devices include CT, MRI, Ultrasound, X-ray, Implants and 
Assistive devices. Table 1 shows China’s medical market trade statistics according to 
the China Chamber of Commerce for Import & Export of Medicines & Health 
Products (CCCMHPIE) in 2010. The overall trend of the Chinese healthcare market 
shows that export value is higher than import value; hence the export value of the 
pharmaceutical and medical device industry is higher than the import value. However, 
the import value of medical diagnosis and treatment devices is higher than the export 
value, which took a 29.05% share of total import volume in China. By comparison, 
medical dressings, disposable products, health protection and recovery products, 
dental equipment and materials, total only 6.8% of import volume, which is only 
one-quarter of the import volume of the medical diagnosis and treatment sector. China 
has a greater demand for medical diagnosis and treatment devices. This is why 
China’s medical device market is dominated by the US, Germany and Japan. 
     
Table 1  
China’s import and export structure of medicines and health products, 2010. 
                                                 (Unit: 10,000 USD)  
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Source: CCCMHPIE, 2011 (China Chamber of Commerce for Import & Export of 
Medicines & Health Products, 2011a) 
 
    More specifically, Table 2 illustrates the trade statistics for medical devices in 
China in 2010. The total export value of medical devices reached USD 13.86 billion 
in 2010, while the total import value reached USD 7.3 billion. North America and 
Asia are the main export target areas for China, which accounted for 29.23% and 
33.7% of the total export volume; the U.S. and Japan are the main export target 
countries, which absorbed 27.91% and 10.39% of the total export volume respectively. 
Europe and North America are the main exporters to China, which accounted for 
39.01% and 31.41% of the total import volume. Germany and the U.S. are the main 
importing countries, which provide 17.34% and 30.71% of the total import volume. 
 
Trade name Export Value 
(*10
4
) 
Export 
value 
growth 
rate 
annually 
(%) 
Share 
in total 
export 
volume 
(%) 
Import 
Value 
(*10
4
) 
Import 
value 
growth 
rate 
annually 
(%) 
Share 
in total 
import 
volume 
(%) 
Total 3,973,310.23 24.87 100 2,046,435.6 23.98 100 
1.Traditional 
Chinese Medicine 
194,447.12 22.78 4.89 68,794.91 22.61 3.36 
2.Pharmaceuticals 2,393,002.43 28.17 60.23 1,244,083.7 20.53 60.79 
3.Medical Devices 1,385,860.67 19.83 34.88 733,556.93 30.45 35.85 
3.1 Medical 
dressings 
468,750.68 11.95 11.8 20,776.8 25.63 1.02 
3.2 Disposable 
products 
192,227.35 15.42 4.84 88,076.07 27.73 4.3 
3.3 Medical 
diagnosis 
and 
treatment 
454,359.93 25.56 11.44 594,472.93 30.34 29.05 
3.4 Health 
protection 
and 
recovery 
products 
241,640.74 30.87 6.08 14,937.21 83.83 0.73 
3.5 Dental 
equipment 
and 
materials 
28,881.97 16.51 0.73 15,293.93 21.37 0.75 
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Therefore, according to Table 1 and Table 2, China export medical products such as 
medical dressings, disposable products, health protection or recovery products and 
dental equipment or materials to North America and Asia while it imports medical 
diagnosis and treatment devices from North America and Europe. 
Table 2  
China’s import and export markets of medical devices, 2010.   (Unit: 10,000 USD)  
 
Source: CCCMHPIE, 2011 (China Chamber of Commerce for Import & Export of 
Medicines & Health Products, 2011b) 
 
    Foreign investment took place because of the product and factor market 
imperfections (Hymer, 1976). Researchers proposed the relationship between market 
imperfections and sustainable opportunities, by recognizing and combining known 
supply and demand elements of the market (Cohen & Winn, 2007). For the Chinese 
medical device market, with growth from many sources of demand (unmet clinical 
needs, aging population, disease profiles, etc.), medical diagnosis and treatment 
devices still have a great growth potential in China. China now has a fee-for-service 
healthcare system financed largely by payments from patients, employers and health 
insurance companies (Chen, 2001). However, many patients, especially high income 
ones are willing to pay more for better treatment. This is particularly obvious for 
patients with cancer, heart disease and cerebrovascular disease that need to use 
high-tech medical diagnosis and treatment devices or high-grade drugs, which are not 
affordable for low income people. For example, the average fees for a CT whole body 
scan is nearly 2500 RMB (about USD 400) in China, this is not a small expenditure 
for low income people, they always choose the most economic ways to treat their 
diseases. However, China’s health institutions especially the first class hospitals have 
a strong demand for high-end diagnostic devices due to the rising number of visits and 
inpatients, changed disease profiles etc.     
Country Export Value 
(*10
4
) 
Export 
value 
growth 
rate 
annually 
(%) 
Share 
in total 
export 
volume 
(%) 
Import 
Value 
(*10
4
) 
Import 
value 
growth 
rate 
annually 
(%) 
Share 
in total 
import 
volume 
(%) 
Total (All 
countries) 
1,385,860.67 19.83 100 733,556.93 30.45 100 
Asia 466,995.82 12.87 33.7 193,877.25 29.28 26.43 
Europe 363,106.46 18.53 26.2 286,137.63 34.38 39.01 
North America 405,103.32 24.48 29.23 230,378.6 25.81 31.41 
       
1. U.S. 386,760.61 24.72 27.91 225,263.7 26.48 30.71 
2. Germany 77,806.39 14.72 5.61 127,173.94 35.43 17.34 
3. Japan 144,007.49 -13.5 10.39 111,390.48 26.99 15.18 
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3. Data and methods 
3.1. Data 
   The data sources are mainly collected from government reports: (1) Ministry of 
Health of the People’s Republic of China (now called National Health and Family 
Planning Commission of the People’s Republic of China); (2) National Bureau of 
Statistics of the People’s Republic of China; (3) United Nations (UN) and their 
organizations and specialized agencies such as the International Monetary Fund (IMF), 
World Bank and World Health Organization (WHO); (4) Some non-commercial 
agents such as China Association for Medical Devices Industry (CAMDI), China 
Association of Medical Equipment (CAME) and Chinese Hospital Association (CHA). 
Other data is collected from independent consulting companies such as Frost & 
Sullivan and Espicom Business Intelligence. The World Bank is an important source 
of finance and provides significant technical assistance to developing countries. The 
WHO focuses on international public health. The purpose of using these data sources 
is to understand the vitality of Chinese healthcare expenditure and the requirements of 
the Chinese population, which is helpful to identify the medical device market 
investment potential in China.  
   Data extracted from the National Bureau of Statistics of the People’s Republic of 
China (China Statistical Yearbook) and Ministry of Health of the People’s Republic of 
China (China Health Statistical Yearbook) from year 2000 to 2011, is presented in 
Table 3.  
 
Table 3 
Chinese healthcare related data. 
Time 
Number of 
hospital 
visit 
(Billion) 
China 65+ 
population 
(Billion) 
China total healthcare 
expenditures (Billion 
RMB) 
Hospital 
quantity 
(Units) 
China medical 
devices revenues  
(Billion RMB) 
2000 1.286 0.089 458.663 16,318 14.5 
2001 1.250 0.091 502.593 16,197 17.3 
2002 1.243 0.093 579.003 17,844 20.7 
2003 1.213 0.095 658.41 17,764 24.7 
2004 1.305 0.097 759.029 18,393 29.5 
2005 1.387 0.099 865.991 18,703 35.3 
2006 1.471 0.101 984.334 19,246 43.4 
2007 1.638 0.103 1157.397 19,852 53.5 
2008 1.782 0.105 1453.54 19,712 65.9 
2009 1.922 0.107 1754.192 20,291 81.2 
2010 2.040 0.11 1998.039 20,918 120 
2011 2.259 0.113 2434.591 21,979 147 
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   The China Statistical Yearbook datasets contain data from every mainland Chinese 
province and city except: Hong Kong, Macao and Taiwan. It also includes the most 
important Chinese statistical data, which is an annual digest of economic and social 
development. China’s total healthcare expenditures and hospital numbers are 
extracted from the China Statistical Yearbook, 2013. The major data sources are 
obtained from annual statistical reports and sample surveys. The number of hospital 
visits are available from the China Health Statistical Yearbook, 2012. This study does 
not include lower level health institutions in the hospital quantity, such as Grass-roots 
Health Care institutions
4
, Specialized Public Health Institutions
5
 and other 
Institutions. This is because, in China, medical diagnosis devices are always located 
in hospitals as other health institutions do not have the resources to purchase these 
expensive medical devices. Data on the numbers of Chinese aged 65 and above were 
collected from the UN Population Division. China’s medical devices revenues were 
extracted from CAMDI.  
3.2. Methods 
   This study analyses the Chinese medical device market using a combination of 
qualitative (official statistics and secondary analysis) and quantitative research 
methodologies (regression analysis). In this article many data sets are collected from 
official statistics, which are created by government departments or other organizations. 
Although there is some limitation to secondary analysis and official statistics, many 
researchers still use this method to analyze markets because it saves cost and time, 
gives access to high-quality data and provides the opportunity for longitudinal and 
cross-culture analysis, etc. (Bryman, 2012). Some forms of official statistics are very 
precise, such as births and deaths data (Bryman, 2012) and population census data 
(Bryman & Bell, 2011). Data analysis makes the developing trends more clearly 
understandable. Trend analysis can be used to predict the future value of the market. 
More and more researchers have started to focus on the past and its importance for 
understanding the present situation and for predicting the future more effectively via 
in-depth historical analysis.  
   In the population section, this article uses Neural Network Time Series prediction, 
to predict the total Chinese population and the number of 65 year olds and above from 
2011 to 2020. Neural Networks are widely used in many areas but few researchers 
have used it for population prediction. This article analyses the data trends from the 
past to the present using longitudinal analysis, which shows the importance and 
changing trends for medical devices demand.  
    The most important drivers of the Chinese medical device market are: number of 
hospital visits; population above 65 years old; total healthcare expenditures and the 
number of medical institutions. Linear regression analysis is an effective method for 
                                                             
4
 Grass-roots Health Care institution include community health centre and station, sub-district health centre, 
village clinic, outpatient department, and, clinic (infirmary) 
5
 Specialized Public Health Institution include Chinese Center for Disease Control and Prevention (CDC), 
specialized disease prevention and treatment institution, health education centre, maternal and child health centre, 
emergency centre, centre for blood collection & supply, centre for health supervision and centre for family 
planning service.  
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studying the relationships and relative importance of these drivers. To evaluate the 
Chinese medical device market investment potential, we need to understand its 
revenues. China’s medical device revenues is the dependent variable ‘y’, the 
independent variables ‘x’ are: number of visits (x1), Chinese population above 65 
years old (x2), Chinese total healthcare expenditure (x3) and the number of Chinese 
hospitals (x4). Suppose the dependent variable y is combined with one independent 
variable xi and two parameters, β0 and β1:  
   yi = β0 + β1xi, i=1,2,…,n.           (1)                                    
Microsoft Excel is used for correlation analysis. We also used MATLAB for 
correlation analysis and obtained the same results. Using the official data in Table 3; 
after correlation, we conclude the relationship between number of hospital visits (x1) 
and China’s medical devices revenues (y) is:  
   y1 = -127.35 + 116.05 x1          (2) 
The multiple R is 0.98, which means that medical devices revenues have a very 
positive correlation with the number of visits. In summary, the correlation equation 
means that every one million change in the number of visits will cause a positive 
change of 116.05 million in medical devices revenues. 
    The same methodology is used for correlation analysis of the other factors. After 
calculation, the relationship between China’s 65+ population (x2) and medical devices 
revenues (y) is:  
   y2 = -470.54 + 5236.43 x2                         (3)      
The multiple R is 0.94, which means there is a very positive correlation between 
China’s 65+ population and medical devices revenues. In summary, the correlation 
equation means that every one million change in China’s 65+ population will cause a 
positive change of 5236.43 million in medical devices revenues.   
    The relationship between China’s total healthcare expenditure (x3) and medical 
devices revenues (y) is:  
   y3 = -19.53 + 0.07 x3                             (4) 
The multiple R is 0.99, which means every one billion change in total healthcare 
expenditure will cause a positive change of 0.07 billion in medical devices revenues. The 
relationship between hospital quantity (x4) and medical devices revenues (y) is:  
   y4 = -364.46 + 0.02 x4                             (5)  
The multiple R is 0.91, which means every one million change in hospital quantity will 
cause a positive change of 0.07 million in medical devices revenues. 
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4. Analysis 
4.1. Number of hospital visits 
    From 2000 to 2011, the compound annual growth rate (CAGR) of hospital visits 
was 5.26%. According to the previous analysis, the correlation equation (2): y1 = 
-127.35 + 116.05 x1 means that every one million change in number of hospital visits 
will cause a positive change of 116.05 million in medical devices revenues. This 
result shows that the number of hospital visits is a vital contributor to the Chinese 
medical device market. One more thing we need to be aware of is that, grass-roots 
health care institutions account for more than 90% of the total number of medical and 
health institutions in China. However, the CAGR of grass-roots health care institution 
visits was lower than the hospital visits at about 1.16%. The main reason for this 
situation is the technology level of the medical devices in these health care institutions 
was lower than in hospitals. With the recent reform of China’s healthcare system, this 
situation is changing. Thus, the speed of upgrading medical devices will cause 
substantial growth in the coming years.  
4.2. 65+Population in China 
    According to the previous analysis, the correlation equation (3): y2 = -470.54 + 
5236.43 x2, means for every one million change in China’s 65+ population will cause 
a positive change of 5236.43 million in medical devices revenues. It is clear that 
population, especially the 65+ population, is the most important driver of the medical 
device market.  
4.2.1. Population and aging in China 
    The UN identifies, populations who have reached the age of 60 years as “older 
population” (Huber, 2005). Moreover, the UN considers a country to be aging when 
10% of their total population is aged over 60 or 7% of their total population is aged 
over 65 (Zhang, 2012). According to the National Bureau of Statistics of China’s 
Sixth National Population Census
6
 in 2010 (National Bureau of Statistics of China, 
2011b), the total population of China reached about 1.37 billion, where people aged 
60 and above accounted for about 0.18 billion (13.26% of the total population), 
people aged 65 and above accounted for about 0.12 billion (8.87% of the total 
population). However, according to the IMF and UN statistics, China has 0.11 billion 
people that are over 65, which is 8.19% of the total population (1.34billion). Which 
means that China has entered the “aging society” category.  
   We can see the changing trend of the Chinese population between 1980 to 2010 
                                                             
6
 Peoples Republic of China have six national population census before. The first one was in the year of 1953, 
second one was in 1964, third one was in 1982, then 1990, 2000 and 2010. 
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from the IMF World Economic Outlook database, 2012 (International Monetary Fund, 
2012), see Figure 3. In addition, it is necessary to understand China’s profile in 
respect of the “aging society”. There is no direct data on the percentage of 65 years 
olds and above from 1980 to 2010, but we can extrapolate how many 65 years olds 
and above there are from the UN Population Division (United Nations, 2011). After 
calculation, we can evaluate that the approximate percentage of 65 year olds and 
above in China from 1980 to 2010, see Figure 4. The IMF and UN data is given in 
Figure 3 and Figure 4. All the data is shown in Appendix B, Table B.  
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Fig. 3. Chinese population from 1980 to 2010. 
Source: IMF, 2012 (International Monetary Fund, 2012) 
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Fig. 4. Percentage of 65 year old and above population in China from 1980 to 2010. 
Source: UN, 2011 (United Nations, 2011) 
 
   From the year of 1990 to 2010, the Chinese population increased from 1.14 billion 
to 1.341 billion. However, the population growth rate declined since 1990 according 
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to the World Bank database (The World Bank, 2012c). Figure 5 shows the trend of 
Chinese population growth rate from 1980 to 2010; data taken from Appendix B, 
Table B. The total population increased slowly, but the population growth rate 
decreased year by year since 1990 due to the decrease in fertility and mortality 
(Cheng, Rosenberg, Wang, Yang, & Li, 2011). The reduction in population growth 
rate speeds up the growth in the aging population. An important need of the “aging 
society” is high quality healthcare, because the elderly are experiencing increasing 
rates of chronic diseases (Grimard, Laszlo, & Lim, 2010). Therefore, the medical 
device market in China is set to expand. 
 
Fig. 5. China population growth rate from 1980 to 2010. 
Source: The World Bank, 2012 (The World Bank, 2012c) 
4.2.2. Neural networks time series prediction 
   Prediction is used in a number of areas. Recently there has been a growing interest 
in applying neural networks to dynamic systems identification, prediction and control 
(Pham & Liu, 1995). Back Propagation (BP) Neural Networks are widely used with 
great success. McClelland, Rumelhart and Hinton (Rumelhart, McClelland, & 
University of California San Diego. PDP Research Group., 1986) established the 
Parallel Distributed Processing (PDP) models. The PDP research group proposed the 
BP algorithm, this method solved the problem of a lack of suitable training methods 
for the multilayer perceptron (MLP), and this greatly assisted the development of 
neural networks.  
   Neural networks are increasingly used by business and management for prediction 
and systems optimization. This includes financial analysis and forecasting (Sharda & 
Patil, 1992), bankruptcy prediction (Odom & Sharda, 1990) and stock market 
prediction (Mohan & Indian Institute of Management Ahmedabad., 2005). Luo and 
Huang (R. Luo & Huang;, 2004), Xie and Li (Xie & Y. Li, 2009) have discussed the 
prediction of population based on neural networks. 
   We use neural network time series prediction in this article. This is a simple way 
to predict population. In the neural network time series prediction, the method of 
nonlinear autoregression (NAR) (MathWorks MATLAB, 2011a) has been chosen 
because there is only one series involved (here it is Population). The future value 
0
1
2
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schema of a time series y(t) is shown in Figure 6. 
 
 
 
 
 
 
Fig. 6. Diagram of NAR neural network. (MathWorks MATLAB, 2011a) 
 
   Using a neural network time series prediction based on the real population from 
1980 to 2010, the predicted total population in China from 2011 to 2020 is 
extrapolated in Figure 7. Data is shown in tabular form in Appendix C, Table C.1. 
 
Fig. 7. Real Chinese population and predicted population. 
 
   After training many times, it was found that the optimum number of delays is 5, and 
the number of hidden neurons are 16 (see Figure 8), this minimized the error of the 
neural network
7
 to 0.029528, which gives the best prediction performance. Detailed 
data is shown in Appendix C, Table C.2. 
 
 
 
 
 
 
 
                                                             
7
 Neural network error= 


2010
1980
2)(
i
ii DP ,where Pi is year i population, Di is year i predicted population. 
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Fig. 8. Diagram of NAR neural network used for Chinese total population prediction. 
 
   The data shows that the Chinese total population in 2011 and 2012 is 1,344.13 
million and 1,350.70 million respectively, while the results of the neural network time 
series prediction shows the population is 1,342.32 million (2011) and 1,347.63 million 
(2012) (The World Bank, 2013). The error is relatively small and a reliable prediction 
has been achieved. Therefore, a Neural Network performs well in predicting the 
population. This method is used to predict the 65 year old and above population in 
China, with results illustrated in Figure 9.  
 
Fig. 9. Real Chinese 65+ population and predicted 65+ population 
 
   Predicting the population for 65 year olds and above permits prediction of a major 
element of the future value of the medical device market based on past records. Fig. 9 
illustrates the real Chinese aged 65 and over population from 1980 to 2010 and the 
predicted 65 year olds and above population from 2011 to 2020. The predicted 
Chinese 65 year olds and above population from 2011 to 2020 is reported in Appendix 
C, Table C.1.  
4.3. China total healthcare expenditures and the number of hospitals 
    According to the regression results, although China’s total healthcare 
expenditures and the number of hospitals have a positive relationship with medical 
devices revenues; compared with the number of hospital visits and 65+ population, 
the contributions are relatively small, as they cause a positive change of 0.07 and 0.02 
in medical devices revenues respectively.      
    China now has hundreds of thousands of medical and healthcare institutions; 
increasing numbers of hospital visits; unmet medical needs has made these medical 
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and health institutions require more and more medical devices. China has a large 
population, who have experienced rapid economic development, which has resulted in 
continuous improvement of people’s living standards; the descending population 
growth rate in China, means that the aging population has become a vital element in 
driving the medical device market. China’s medical device industry is in a period of 
development and expansion, there are very broad market opportunities. The huge 
demand provides a good market opportunity for medical device companies. The 
number of medical and health institutions, and visits and inpatients in health 
institutions has experienced growth every year; consequently there is an increased 
demand for medical devices, especially for good quality, multi-functional medical 
systems. The frequency of use of medical devices will accelerate and the renewal 
period will be shortened. The improvement of Chinese medical and health services 
provides a good development platform and market capacity for the Chinese medical 
device industry.   
    We used quantitative methods to evaluate China’s medical devices market 
investment potentials, but we cannot use the quantitative methods to calculate the 
other main important drivers of the Chinese medical device market, such as the 
ownership rate of medical devices among the main hospitals and disease profiles.  
4.4. The ownership rate of medical devices among the main hospitals 
    The China Health Statistical Yearbook summarized the number of medical 
devices in the main hospitals and the percentage of medical devices in the main 
hospitals in China before 2004. Although no official data was collected after 2004, we 
can get some data from other agents such as CAME and CHA in order to explore the 
medical device market investment situation in China. Table 4 and Table 5 show the 
number and percentage of medical devices in the main hospitals in China. 
  
Table 4 
Number of medical devices in the main hospitals in China (units). 
Device Name    
               Year               
 
1996 
 
1998 
 
2000 
 
2001 
 
2004 
Electrocardiograph 35,295 41,230 46,122 48,073 --- 
B-mode ultrasound 19,077 21,842 23,911 24,893 19,653 
Color Doppler ultrasound 2,455 4,596 5,110 5,926 7,613 
CT 2,549 3,543 4,247 4,760 4,752 
MRI 356 512 604 714 1,110 
Cardiac Monitor 19,108 27,580 39,995 47,024 --- 
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Source: China Health Statistics, (Ministry of Health of the People's Republic of China, 
2004a, 2007a) 
     
Table 5 
Percentage of medical devices in the main hospitals in China (%). 
 
Source: China Health Statistics, (Ministry of Health of the People's Republic of China, 
2004a, 2007a) 
 
   Nearly 90% of the main hospitals purchased Electrocardiograph and B-mode 
ultrasound, because electrocardiograph and B-mode ultrasound are relatively cheap 
and are used widely, ordinary people can afford the diagnostic fees. Moreover, many 
of electrocardiograph and B-mode ultrasound devices are indigenous products, there 
is massive competition especially price competition in this area, which has reduced 
the profit margins, investment in these devices will not gain more profits. Table 4 
illustrates that the units for Cardiac Monitoring were 47,024 in 2001, almost the same 
as Electrocardiograph, but its percentage in the main hospitals accounts for 49.8%, 
this is a large difference between Electrocardiograph’s 93.7% in 2001. It means that 
with the high growth rate of the number of Cardiac Monitors, according to Table 4, 
the market for Cardiac Monitors still has room for expansion. From both Table 4 and 
Table 5 we can understand that the market for Color Doppler ultrasound, CT and MRI 
has great investment potential, especially MRI. This situation is caused for many 
reasons including the disease profiles, which are described below. 
   Today the hospital’s reputation is said to rely on them possessing the latest and 
most expensive medical devices such as Color Doppler ultrasound, CT and MRI 
(Schulze, 2001), because most hospital’s revenues are generated by these expensive 
medical devices. In 1996, China had 2,549 CT scanners, 2,455 Color Doppler 
ultrasound and 356 MRIs. The increasing speed of adoption of these medical devices 
is impressive. Until 2004, China had 4,752 CT scanners, 7,613 Color Doppler 
ultrasound and 1,110 MRIs (see Table 4). According to CHA’s report (Chinese 
Hospital Association, 2012), China had 9,109 CT scanners in 2008, 10,101 CT 
scanners in 2009 and 11,242 CT scanners in 2010. With the increasing number of 
CT’s in China, China had 5.5 CT scanners per million people in 2006, which 
increased to 8.6 CT scanners per million people in 2010, which shows a rapid growth. 
However, compared with other countries, the ownership rate of CT devices is 
Device Name 
         
        Possession Rate 
 
1996 
 
1998 
 
2000 
 
2001 
 
2004 
Electrocardiograph 88.1 90.2 92.8 93.7 --- 
B-mode ultrasound 87.1 89.3 91.8 92.7 83.0 
Color Doppler ultrasound 15.4 22.0 29.0 32.8 35.7 
CT 17.8 22.6 27.7 30.6 29.2 
MRI 2.5 3.2 4.0 4.8 7.2 
Cardiac Monitoring 39.3 43.4 48.2 49.8 --- 
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relatively low. For example, Japan had 98 CT scanners per million people in 2006. 
Therefore, it can be predicted that there will be huge future demand for this kind of 
medical device in China. 
4.5. The main diseases in China 
   In China, with the increase in the population of elderly people; the improvement 
of people's living standards; population movements and the accelerated process of 
urbanization, disease profiles have altered significantly.  
   China now belongs to the upper middle income countries (The World Bank, 
2012a); of the top ten leading causes of death in the middle income countries, seven 
are chronic disease-related deaths, which accounted for 91% of total deaths (World 
Health Organization, 2008). The higher burden of chronic diseases in low- and middle 
income countries is well described by China (Merson, Black, & Mills, 2012), which 
means these diseases will cost a great deal. Although digestive diseases, respiratory 
diseases, infectious and parasitic diseases are the top ten leading cause of death in 
low- and middle income countries, we need to focus more attention on cancers, 
cardiovascular diseases and cerebrovascular diseases, which account for the top three 
percent of total deaths in China (World Health Organization, 2008). 
   Figure 10 and Figure 11 show the percentage of total deaths from the top five 
main diseases in Chinese cities and counties from 2003 to 2011. All the data are 
collected from the Ministry of Health of the People’s Republic of China health 
statistics. Detailed data is shown in Appendix A, Table A.1. (city) and Appendix A, 
Table A.2 (county). Due to the scarcity of data; the years of 2007 and 2010 are not 
included.  
   Figure 10 illustrates the percentage of total deaths from the top 5 main diseases in 
China’s cities from 2003 to 2011. By comparison, the top three leading causes of 
death in middle-income countries are cardiovascular diseases, cerebrovascular 
diseases and respiratory diseases (Beaglehole & Yach, 2003; Kirton, 2009; Merson, et 
al., 2012), there were 2.8 million deaths from cardiovascular diseases in China in 
2003 (Beaglehole & Yach, 2003). China has a different profile when compared with 
other middle-income countries. Cancers caused the highest mortality in China and has 
maintained the first position among the five leading causes of death in both the cities 
and counties of China, except in 2005, according to Figure 11. The major risk factors 
causing cancers are tobacco consumption, chronic infections, diet and lack of physical 
activity, etc. (Stewart, Kleihues, & International Agency for Research on Cancer., 
2003). 
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Fig. 10. Percentage of total deaths from the top 5 main diseases in Cities 
Source: China Health Statistics, (Ministry of Health of the People's Republic of China, 
2004b, 2005, 2006, 2007b, 2008, 2009, 2010, 2012) 
 
   Compared with Figure 10 and Figure 11, cancers, cardiovascular diseases and 
cerebrovascular diseases are the top three causes of death in cities in China, but we 
cannot neglect respiratory diseases, which accounted for 23.45% of deaths in the 
counties of China in 2005 (see Appendix A, Table A.2.). Major risk factors for 
respiratory diseases include air pollution, tobacco consumption, occupational long 
term exposures, etc. (Ait-Khaled, Enarson, & Bousquet, 2001). Cerebrovascular 
diseases have reached second place among the ten leading causes of death in the 
developing countries, as well as in China. Major risk factors for cerebrovascular 
diseases are tobacco consumption, obesity and life stress, etc. Injury, poisoning and 
external causes are ranked in position five of the leading causes of death in both the 
cities and counties in China. From analysis of these diseases, it can be seen that 
tobacco is the greatest cause of health problems. Several diseases and conditions were 
added to the lists as being causally related to smoking (U.S. Department of Health and 
Human Services (DHHS), 2004). 
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Fig. 11. Percentage of total deaths from the top 5 main diseases in the County regions.  
Source: China Health Statistics, (Ministry of Health of the People's Republic of China, 
2004b, 2005, 2006, 2007b, 2008, 2009, 2010, 2012) 
 
   Cancer is a leading cause of death globally, accounting for 7.6 million deaths in 
2008 (World Health Organization, 2013). Nearly 70% of cancer deaths occurred in 
low- and middle-income countries. It is predicted that deaths from cancer will 
increase, with an estimated 13.1 million deaths in 2030 (International Agency for 
Research on Cancer, 2010). Cancer is a big problem for the society worldwide as well 
as for China.  
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5. Discussion 
    Our data suggests that the Chinese medical device market is not only driven by 
the four variables (number of hospital visits; 65+ population; total healthcare 
expenditures and number of hospitals) that were discussed earlier but is also impacted 
by the ownership rate of medical devices and the diseases profile, for example cancer. 
Results from regression analysis suggest that aging (mainly for people aged 65 and 
above) is one of the important drivers of the Chinese medical device market. The 
correlation coefficient informs us about the direction and the relationship strength 
between the dependent variable and independent variables. Interestingly, total 
healthcare expenditure and hospital quantity are not the major factors (compared with 
65+ population and number of hospital visits) in controlling the Chinese medical 
device market but have a positive correlation. Furthermore, our data indicates that the 
ownership rate of medical devices among the main hospitals and disease profiles are 
important (but not easily quantified) in driving the medical device market.    
    Regression analysis illustrates that people aged 65 and above play an important 
role in China’s medical device market. According to Gu’s research, Chinese 65+ years 
population are projected to be 236 and 334 million by the years 2030 and 2050, 
respectively (Gu, Dupre, Warner, & Zeng, 2009). Therefore, due to the importance of 
the aging population in China, we used neural network time series prediction to 
estimate the total population and 65+ population from 2010 to 2020. Prediction results 
show that there is a smooth rising trend of Chinese 65+ population from 2010 to 2020, 
revealing that aging population plays an important role in the Chinese healthcare 
industry, which indicates that the Chinese medical device market has possible 
investment opportunities in the future.  
    The purpose of medical devices is to assist with: patient’ stratification, diagnosis, 
prognosis, treatment and treatment planning; the macroeconomic variables such as 
population structure; disease profiles and economic level can affect the demand for 
medical device services. Disease profiles affect the development of medicine as well 
as medical device capabilities and the total medical device market. Therefore, diseases 
should be one of the elements driving medical device industrial investment. The top 
five diseases have a significant impact on China’s economy via healthcare costs and 
lost productivity. Popkin et al (Popkin, Horton, Kim, Mahal, & Shuigao, 2001) 
estimated that diet-related chronic diseases (cancer, cardiovascular diseases, 
cerebrovascular diseases and diabetes, etc.) accounted for 22.6% of healthcare costs in 
China, while the cost of lost productivity due to these diseases was about 0.5% of 
GDP in 1995. Cancer is still a big challenge for the world as well as for China. The 
top five cancers (Lung, liver, stomach, oesophagus and colorectal) in China in 2004 
still maintained their position in 2008; all cancers have a smooth rising trend except 
breast cancer, which shows an rapid increase of 4.02% in mortality rate from 2004 
(2.88%) to 2008 (6.9%) (Ministry of Health of the People's Republic of China, 2012). 
Among the main cancers in China, breast cancer is a growing problem; further 
investment in research and facilities to combat breast cancer in China is 
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recommended.  
   If the incidence or mortality from the disease is low, the demand and frequency of 
use of the appropriate diagnosis and treatment equipment will be relatively low, the 
investment payback period for such medical devices will be long for hospitals; in such 
a scenario, it is difficult for hospitals to recover the cost of medical devices 
throughout their entire life cycle. So only the large general hospitals will consider 
purchasing such medical devices. Small and medium-sized hospitals do not have the 
capacity to buy such medical devices. Thus, the market demand for medical devices 
with low disease incidence is relatively small; investment risk is large and does not 
have investment value. If the incidence or mortality of the disease is high, the demand 
and frequency of use of the appropriate diagnosis and treatment equipment will be 
relatively high, the large general hospitals will be very motivated to purchase such 
medical devices as well as small and medium-sized hospitals because the investment 
payback period for such devices will be short. 
    With the advancement of medical technology, the diseases which threaten human 
life are changing as well. Cancers, cerebrovascular diseases, cardiovascular diseases 
and respiratory diseases will become the major diseases which threaten human health 
and life in the 21
st
 century. With the gradual increase in the number of patients and 
mortality, the demand for diagnosis and treatment devices will inevitably increase. 
Good market prospects indicate that medical devices for these diseases have great 
investment potential.  
    Medical devices demand analysis is the basis of industrial investment 
opportunities. This study predicts the medical device market demand based on disease 
profiles and the extent of the medical device market saturation. In a perfectly 
competitive market, the prices of all products and services in an industry are 
determined by equating the demand for a good with its supply (Cohen & Winn, 2007). 
In the economics area, there is a principle that as “the price of a good or service rise, 
the quantity demand falls”, this is the price elasticity of demand. However, research 
reports that the demand for medical technology is extremely inelastic (it does not rely 
on price) and free of this principle “competition will make prices fall, narrowing 
margins and reducing profits” (Kruger, 2005). Other arguments show that the demand 
for most new products tends to be based on non-price factors (Hill, 2009). The 
medical device market has sustainable growth because of the general demographic 
trends, especially the growth of the aging population and the continued prevalence of 
diseases (Kruger, 2005). For the Chinese medical device market, the growth of 
medical services institutions, medical diagnosis and treatment devices, disease 
profiles and population - especially the aging population, means that the market has 
great investment potential. 
    The main medical devices companies’ investment activities and/or mergers and 
acquisitions in China give good indicators of how the market is developing. For 
example: Philips Healthcare (Philips Healthcare, 2012) established medical imaging 
bases in Suzhou (Jiangsu Province) in 2009 and purchased Shanghai Apex Electronics 
in 2010 for ultrasound production. GE Healthcare (General Electric, 2012) is to form 
a joint venture with Shinva Medical Instrument in Zibo (Shandong Province), which 
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was the first medical devices company in China (established in 1943). GE Medical 
Industrial Park (Beijing) is one of the largest research and development (R&D) bases 
in the world. The partnership, aims to be active in R&D, and manufacturing/sales, the 
production of medical devices includes: Computed Tomography (CT), Magnetic 
Resonance Imaging (MRI) and X-rays. The revenues from GE Healthcare was one 
billion US dollars in China in 2008 with increasing sales performance. Siemens 
Healthcare (Siemens Healthcare, 2012) has two wholly owned subsidiaries in China, 
one named Siemens Shanghai Medical Equipment Ltd. (founded in 1992) in Shanghai, 
which is a research and development base and manufactures CT and X-ray systems; 
the other one is Siemens Shenzhen Magnetic Resonance Ltd. (founded in 1998) in 
Shenzhen (Guangdong Province). Hitachi (Hitachi Medical Systems, 2012) 
established three Medical Systems Corporations in Suzhou, Beijing and Guangzhou. 
Toshiba Medical System (China) Corporation Ltd was established in Beijing in 2007 
for developing CT devices. All these activities contribute to China’s medical device 
industrial growth. Moreover, the Chinese government has developed rural areas 
healthcare systems in recent years and this investment is continuing, this creates more 
investment potential for investors. Therefore, foreign investment can make a positive 
contribution to a host country by supplying capital, management resources and 
technology that would otherwise not be available and this increases the country’s 
economic growth rate (Li & Liu, 2005; Lipsey, 2002); enhanced technology prowess 
can stimulate further economic development and industrialization (Hill, 2009). So, 
China is a market with fabulous investment potential for health care providers and 
medical device manufacturers (Schulze, 2001).  
   As with many studies, this study has several limitations. Some of the data from the 
government report is hard to access, for example: the number and percentage of 
medical devices in the main hospitals in China, for which data was only reported for 
the years of 1996, 1998, 2000, 2001 and 2004. Trying to use questionnaires is 
unreliable. Generally speaking, the scarcity of data does not have a big impact on the 
main results. Data deficiency is a major problem faced by most countries. The number 
of medical devices in Chinese hospitals after 2004 is hard to access from the Chinese 
Ministry of Health database. We selected four important drivers of the Chinese 
medical device market, because we can access this data to use quantitative methods to 
assess the market. The market’s drivers not only include the four drivers and the 
ownership rate of medical devices and disease, but also contains other elements. 
Despite the data limitations, the article describes China’s medical devices current 
market situation and identifies the investment potential of the market. Analysis of the 
prevalence of diseases in China shows that cancers are the big challenge for the whole 
medical area, and that there is an increasing trend in the incidence of death from 
breast cancer, this indicates that there is a requirement for further research and 
analysis in this area.  
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6. Conclusions 
   This study indicates that the Chinese medical device market has great investment 
potential for identified reasons. China has a rapidly developing economy, there is 
government investment in the healthcare industry to improve the medical environment, 
the government is encouraging foreign medical companies to investment in China. 
Some large foreign companies like GE healthcare, Siemens healthcare and Philips 
healthcare continue to increase investment in China. This indicates that the Chinese 
medical device market has significant investment potential for the future. Foreign 
investment will bring both benefits and risks to the country’s health sector (Smith, 
2004). The Chinese medical device market still has room for investment due to the 
growing aging population and the increasing number of hospital visits. Because China 
continues to develop economically and socially, the predominance of infectious 
diseases is decreasing. Chronic diseases (epidemiological transition) are emerging as 
an increasing problem, hence the health care system is experiencing huge pressures 
from both changing and increasing demands (Dummer & Cook, 2008).  
   This study suggests that the Chinese medical device market has great potential and 
shows that medical diagnosis and treatment devices will be in tremendous demand in 
the future. The rising numbers of aging people in China, the changed disease profiles 
and the constant increase in the incidence of chronic diseases like cancers, which 
requires medical diagnosis and treatment devices such as CT, MRI and ultrasound are 
driving this demand. 
   It is noteworthy that China’s high-end medical device market relies on imports 
from the developed countries. These foreign made high-tech medical devices account 
for 70% of China’s medical device market. The number of medical and health 
institutions increased year by year as did the number of visits and in-patients in 
healthcare institutions, this huge and increasing demand provides an expanding 
market for medical devices. Disease profiles determine which kind of medical devices 
have more investment value in China. Demand analysis indicates that Color Doppler 
ultrasound, CT and MRI have great future investment potential in China. The growth 
in the aging population is a big test of the health care industry in China, peoples’ 
desire for good health is stronger than before, therefore significant opportunities exist 
in the medical device market.  
   This article provides the first study of its kind in providing a better understanding 
of China’s medical device market. We hope our study has shed some light on this 
important topic and we encourage more studies for this important market opportunity. 
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Appendix A.  
 
Table A.1. Percentage of Total Deaths of Top 5 Main Diseases in Certain Region from 
2003 to 2011(City) 
                                            
Cause 
          % 
2003 2004 2005 2006 2008 2009 2011 
Cancers 
(Malignant 
Tumors)  
25.47 23.92 22.94 27.25 25.47 27.01 27.79 
Cerebrovascular 
Disease  
19.95 19.09 21.23 17.66 19.95 20.36 20.22 
Cardiovascular 
Diseases 
(Ischemic Heart 
Disease) 
14.43 18.80 17.89 17.10 14.63 20.77 21.30 
Diseases of the 
Respiratory 
System  
14.63 13.12 12.57 13.06 14.63 10.54 10.56 
Injury, Poisoning 
& External 
Causes  
6.16 5.89 8.25 6.10 6.16 5.59 5.47 
Source: China Health Statistics, (Ministry of Health of the People's Republic of China, 
2004b, 2008, 2010, 2012) 
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Table A.2. Percentage of Total Deaths of Top 5 Main Diseases in Certain Region from 
2003 to 2011(County) 
                                            
Cause 
           % 
2003 2004 2005 2006 2008 2009 2011 
Cancers 
(Malignant 
Tumors)  
25.28 23.70 20.29 25.14 25.28 24.26 23.62 
Cerebrovascular 
Disease  
23.75 14.85 21.17 20.36 23.75 23.19 21.72 
Cardiovascular 
Diseases 
(Ischemic Heart 
Disease) 
12.03 12.54 11.77 13.87 12.03 17.21 19.37 
Diseases of the 
Respiratory 
System  
18.72 13.30 23.45 16.40 18.72 14.96 13.31 
Injury, Poisoning 
& External 
Causes  
5.69 6.63 8.47 8.90 5.69 8.25 8.85 
Source: China Health Statistics, (Ministry of Health of the People's Republic of China, 
2004b, 2008, 2010, 2012) 
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Appendix B.  
 
Table B. Chinese population and its relevant data from 1980 to 2010 
 
Year/Ages 
China total 
65 and above 
population 
(millions) 
China total 
population 
(millions) 
Percentages of 
65 and above 
population in 
China (%) 
China total 
population 
growth rate 
(annual %) 
    
 
1980 50.677 987.05 5.13 1.3 
1981 52.697 1,000.72 5.27 1.3 
1982 54.594 1,016.54 5.37 1.5 
1983 56.419 1,030.08 5.48 1.4 
1984 58.218 1,043.57 5.58 1.3 
1985 60.009 1,058.51 5.67 1.4 
1986 61.565 1,075.07 5.73 1.5 
1987 63.149 1,093.00 5.78 1.6 
1988 64.754 1,110.26 5.83 1.6 
1989 66.377 1,127.04 5.89 1.5 
1990 68.05 1,143.33 5.95 1.5 
1991 69.808 1,158.23 6.03 1.4 
1992 71.671 1,171.71 6.12 1.2 
1993 73.608 1,185.17 6.21 1.1 
1994 75.58 1,198.50 6.31 1.1 
1995 77.576 1,211.21 6.40 1.1 
1996 80.073 1,223.89 6.54 1 
1997 82.387 1,236.26 6.66 1 
1998 84.584 1,247.61 6.78 1 
1999 86.749 1,257.86 6.90 0.9 
2000 88.912 1,267.43 7.02 0.8 
2001 91.044 1,276.27 7.13 0.7 
2002 93.202 1,284.53 7.26 0.7 
2003 95.336 1,292.27 7.38 0.6 
2004 97.312 1,299.88 7.49 0.6 
2005 99.087 1,307.56 7.58 0.6 
2006 101.237 1,314.48 7.70 0.6 
2007 103.21 1,321.29 7.81 0.5 
2008 105.163 1,328.02 7.92 0.5 
2009 107.325 1,334.50 8.04 0.5 
2010 109.845 1,340.91 8.19 0.5 
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Appendix C.  
 
Table C.1. The predicted Chinese population from 2011 to 2020 
 
Year/Ages Total China population (millions) Total 65+ population (millions) 
2011 1,342.32 112.71 
2012 1,347.63 115.14 
2013 1,353.85 117.61 
2014 1,354.77 121.50 
2015 1,356.35 125.45 
2016 1,359.52 127.99 
2017 1,362.93 131.16 
2018 1,364.14 135.08 
2019 1,363.05 138.37 
2020 1,365.06 141.98 
 
 
Table C.2. Neural networks 
 
Neurons Neural Network Error (res) 
4 0.049233 
5 0.16097 
6 0.048822 
7 0.1729 
8 0.078508 
9 0.114535 
10 0.171799 
11 0.105598 
12 0.166333 
13 0.127967 
14 0.091731 
15 0.047639 
16 0.029528 
17 0.070366 
18 0.111514 
 
